He also predicts that acquiring such a drug may be as easy as swallowing a pill. Ryazanov says there exists a fine logic to the study and drug development which have become his life's work – as the cancer therapies he really wants to enhance already exist and so are known to work. Making chemo and radiation less toxic, he says, can make those therapies dramatically more effective in the relatively near future, while other cutting-edge methods to cancer treatment may need far more period to prove their supreme worth.. Chemo and radiation may kill more cancer cells and extra healthy ones, suggests Rutgers research What if there were a way to help to make chemotherapy and radiation far better as cancer treatments than they are today, whilst getting rid of debilitating unwanted effects that patients dread also? A new study led by Alexey Ryazanov, a professor of pharmacology at Rutgers Robert Real wood Johnson Medical School and person in the Rutgers Cancer Institute of New Jersey, suggests the day that occurs could be getting closer.Personality could be a risk aspect for CFS and may donate to the maintenance of the condition. Related StoriesSprout announces U.S. Option of Addyi for HSDD treatment in premenopausal womenClinical trial displays nivolumab drug improves general survival, quality of life in lung tumor patientsStudy reveals how brain work network marketing leads to physical fatigueThe investigators utilized the Character Diagnostic Questionnaire, 4th edition, to evaluate DSM-IV character disorders and the NEO Five-Element Inventory, to assess personality features . The Multidimensional Fatigue Inventory measured 5 measurements of fatigue, and the Medical Outcomes Survey Short Type 36 measured 8 measurements of practical impairment.